title: Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus.
abstract: Although drugs used in renal transplant recipients such as steroids, cyclosporine, and particularly, tacrolimus have diabetogenic potential, diabetic ketoacidosis is uncommon. There are few data concerning the long-term follow-up of these patients. Diabetic ketoacidosis occurred in a renal transplant recipient following de novo development associated with tacrolimus.
authors.affiliation: Department of Nephrology, Uludag University, Bursa, Turkey. alpersoy@uludag.edu.tr
authors.forename: A
authors.initials: A
authors.lastname: Ersoy
authors.forename: C
authors.initials: C
authors.lastname: Ersoy
authors.forename: H
authors.initials: H
authors.lastname: Tekce
authors.forename: I
authors.initials: I
authors.lastname: Yavascaoglu
authors.forename: K
authors.initials: K
authors.lastname: Dilek
mesh_terms: D000328:Adult; D016883:Diabetic Ketoacidosis / Q000175:diagnosis*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation / Q000276:immunology*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011183:Postoperative Complications / Q000175:diagnosis*; D016559:Tacrolimus / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus